Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorAin Shams University
About this trial
This study aims to evaluate the applicability of the LASMAR scoring system, derived from hysteroscopy, in predicting surgical outcomes in patients undergoing hysteroscopic myomectomy for submucous fibroids.
Eligibility criteria
Qualifiers
Women aged 18-45 years
Type 0,1,2 Fibroids according to Figo classification.
Symptomatic submucous fibroids: Symptoms include abnormal uterine bleeding, pelvic pain or pressure symptoms, infertility or recurrent pregnancy loss.
Fibroids size ≤ 5 cm in diameter
Disqualifiers
Contraindications to hysteroscopy (e.g., Pregnancy, pyometra, active infection)
Individuals with significant comorbidities (e.g., severe cardiovascular or respiratory diseases, bleeding diathesis).
Cases requiring concurrent procedures (e.g., Laparoscopic surgeries).
Fibroid Size>5 cm.
Trial design
Treatments tested in this trial
- Hysteroscopic Myomectomy
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov